Coeptis Therapeutics Holdings Inc
NASDAQ:COEP
Market Cap (Intraday) | 23.43M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $0.98 |
50-Day MA | $1.10 |
200-Day MA | $1.45 |
Coeptis Therapeutics Holdings Inc Stock, NASDAQ:COEP
105 Bradford Road, Suite 420, Wexford, Pennsylvania 15090
United States of America
Phone: +1.724.934.6467
Number of Employees: 5
Description
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company. It develops innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.